Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -227,461 | -155,018 | -106,231 | -58,213 | -106,793 |
| Depreciation Amortization | -2,501 | -2,830 | -1,932 | -895 | -2,259 |
| Accounts receivable | 27,462 | 29,423 | 29,128 | 4,778 | -28,956 |
| Accounts payable and accrued liabilities | 706 | -3,415 | -3,292 | -1,897 | 4,812 |
| Other Working Capital | 8,900 | 24,635 | 31,755 | -16,616 | -34,375 |
| Other Operating Activity | 1,354 | -12,597 | -4,714 | 8,102 | 55,955 |
| Operating Cash Flow | $-191,540 | $-119,802 | $-55,286 | $-64,741 | $-111,616 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,098 | -2,030 | -1,202 | -446 | -4,315 |
| Purchase Of Investment | -461,521 | -335,490 | -292,332 | -135,001 | -460,301 |
| Sale Of Investment | 683,127 | 468,540 | 277,264 | 199,552 | 460,692 |
| Investing Cash Flow | $218,508 | $131,020 | $-16,270 | $64,105 | $-3,924 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,083 | -4,083 | -4,083 | -4,083 | -12,500 |
| Common Stock Issued | 96,798 | 96,798 | 96,644 | 117 | 12,285 |
| Other Financing Activity | 1,339 | 1,363 | 500 | 537 | 137,769 |
| Financing Cash Flow | $94,054 | $94,078 | $93,061 | $-3,429 | $137,554 |
| Beginning Cash Position | 70,140 | 70,140 | 70,140 | 70,140 | 48,126 |
| End Cash Position | 191,162 | 175,436 | 91,645 | 66,075 | 70,140 |
| Net Cash Flow | $121,022 | $105,296 | $21,505 | $-4,065 | $22,014 |
| Free Cash Flow | |||||
| Operating Cash Flow | -191,540 | -119,802 | -55,286 | -64,741 | -111,616 |
| Capital Expenditure | -3,098 | -2,030 | -1,202 | -446 | -4,315 |
| Free Cash Flow | -194,638 | -121,832 | -56,488 | -65,187 | -115,931 |